Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Kyntra Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 145
- −6 vs. Q3 2022
- Shares held
- 74.9M
- +1.92M (+2.6%) vs. Q3 2022
- Total value
- $1.20B
- +$250.2M (+26.4%) vs. Q3 2022
- New holders
- 18
- 56 more added
- Sold out
- 24
- 49 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $7.54M |
| Q1 2026 | 32 | $7.01M |
| Q4 2025 | 34 | $10.1M |
| Q3 2025 | 32 | $13.9M |
| Q2 2025 | 30 | $5.62M |
| Q1 2025 | 56 | $10.2M |
| Q4 2024 | 70 | $19.2M |
| Q3 2024 | 72 | $18.3M |
| Q2 2024 | 102 | $50.4M |
| Q1 2024 | 111 | $143.9M |
| Q4 2023 | 100 | $62.1M |
| Q3 2023 | 110 | $59.0M |
| Q2 2023 | 153 | $207.9M |
| Q1 2023 | 173 | $1.42B |
| Q4 2022 | 145 | $1.20B |
| Q3 2022 | 152 | $950.1M |
| Q2 2022 | 152 | $746.9M |
| Q1 2022 | 158 | $816.6M |
| Q4 2021 | 164 | $934.6M |
| Q3 2021 | 165 | $656.8M |
| Q2 2021 | 176 | $1.80B |
| Q1 2021 | 199 | $2.47B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Kyntra Bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 176,200 | $2.82M | 0.00% | +145,630+476.4% | Added |
| JPMorgan Chase & Co | 180,054 | $2.88M | 0.00% | +38,183+26.9% | Added |
| Russell Investments Group, Ltd. | 190,274 | $3.05M | 0.01% | +83,821+78.7% | Added |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3.06M | 0.91% | 00.0% | Unchanged |
| UBS Group AG | 195,455 | $3.13M | 0.00% | +153,891+370.3% | Added |
| Barclays PLC | 202,490 | $3.24M | 0.00% | +8,318+4.3% | Added |
| Swiss National Bank | 215,000 | $3.44M | 0.00% | +4,800+2.3% | Added |
| 5AM Venture Management, LLC | 225,583 | $3.61M | 0.97% | +225,583 | New |
| Rafferty Asset Management, LLC | 259,534 | $4.16M | 0.03% | +31,697+13.9% | Added |
| Bank of New York Mellon Corp | 295,252 | $4.73M | 0.00% | −3,618−1.2% | Reduced |
| Renaissance Technologies LLC | 305,600 | $4.90M | 0.01% | −489,400−61.6% | Reduced |
| Bank of America Corp | 346,436 | $5.55M | 0.00% | +142,363+69.8% | Added |
| Janus Henderson Group PLC | 375,844 | $6.02M | 0.00% | +359,198+2,157.9% | Added |
| Caption Management, LLC | 378,882 | $6.07M | 1.02% | +53,882+16.6% | Added |
| Woodline Partners LP | 391,107 | $6.27M | 0.09% | +391,107 | New |
| Goldman Sachs Group Inc | 443,285 | $7.10M | 0.00% | −184,254−29.4% | Reduced |
| Jane Street Group, LLC | 445,089 | $7.13M | 0.01% | +54,236+13.9% | Added |
| Citigroup Inc | 456,645 | $7.32M | 0.01% | −74,827−14.1% | Reduced |
| Morgan Stanley | 467,997 | $7.50M | 0.00% | +127,663+37.5% | Added |
| Pictet Asset Management SA | 494,853 | $7.93M | 0.01% | +130,632+35.9% | Added |
| Logos Global Management LP | 525,000 | $8.41M | 0.99% | +525,000 | New |
| Two Sigma Investments, LP | 564,174 | $9.04M | 0.03% | +116,822+26.1% | Added |
| Nuveen Asset Management, LLC | 567,335 | $9.09M | 0.00% | −25,897−4.4% | Reduced |
| Citadel Advisors LLC | 582,544 | $9.33M | 0.01% | +556,484+2,135.4% | Added |
| Vantage Consulting Group Inc | 605,713 | $9.70M | 5.73% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 648,300 | $10.4M | 0.03% | +12,400+1.9% | Added |
| Charles Schwab Investment Management Inc | 668,483 | $10.7M | 0.00% | +14,381+2.2% | Added |
| Marshall Wace, LLP | 753,546 | $12.1M | 0.03% | −6,441−0.8% | Reduced |
| Alliancebernstein L.P. | 788,738 | $12.6M | 0.01% | +147,750+23.1% | Added |
| Norges Bank | 789,106 | $12.6M | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 818,880 | $13.1M | 0.00% | +20,472+2.6% | Added |
| Eagle Asset Management Inc | 903,132 | $14.4M | 0.09% | +164,502+22.3% | Added |
| Price T Rowe Associates Inc | 928,134 | $14.9M | 0.00% | +894,858+2,689.2% | Added |
| Baker Bros. Advisors LP | 1,375,211 | $22.0M | 0.13% | +559,493+68.6% | Added |
| Jacobs Levy Equity Management, Inc | 1,426,637 | $22.9M | 0.15% | −3,889−0.3% | Reduced |
| Geode Capital Management, LLC | 1,657,095 | $26.5M | 0.00% | +52,068+3.2% | Added |
| Schroder Investment Management Group | 1,760,750 | $28.2M | 0.04% | +381,778+27.7% | Added |
| Adage Capital Partners GP, L.L.C. | 2,650,000 | $42.5M | 0.10% | −100,000−3.6% | Reduced |
| First Trust Advisors LP | 2,975,653 | $47.7M | 0.06% | −650,483−17.9% | Reduced |
| Armistice Capital, LLC | 3,864,000 | $61.9M | 1.66% | −592,000−13.3% | Reduced |
| State Street Corp | 4,264,977 | $68.3M | 0.00% | +40,527+1.0% | Added |
| Point72 Asset Management, L.P. | 4,781,645 | $76.6M | 0.29% | +3,945+0.1% | Added |
| BlackRock Inc. | 7,134,318 | $114.3M | 0.00% | −32,519−0.5% | Reduced |
| Vanguard Group Inc | 9,444,069 | $151.3M | 0.00% | −296,873−3.0% | Reduced |
| Primecap Management Co | 13,895,078 | $222.6M | 0.20% | +715,181+5.4% | Added |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −513,556−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −160,401−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −85,813−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −74,348−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −69,347−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −68,270−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −59,748−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −49,579−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −40,266−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −39,724−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −25,616−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −25,256−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −22,740−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −20,525−100.0% | Sold out |
| Cim Investment Mangement Inc | 0 | $0 | 0.00% | −16,765−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −13,810−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −12,660−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −12,190−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −7,223−100.0% | Sold out |
| Axiom Investment Management LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,639−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Eaton Vance Management | – | – | – | – | Not filed |